MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-17312

  1. 318 Posts.
    lightbulb Created with Sketch. 351
    @Lopez said the following in post #70894360:

    ”Hi Pharma, Also interesting that the Bone and Marrow transplant org attended the last FDA meeting.In my opinion to persuade the FDA that a confirmatory trial will indeed take place allowing Ped approval when theAssaya Data is presented.”

    Isn’t it interesting in light of the fact that the BMT-CTN actually has seriously intended to support the adult GVHD trial, that as Lopez mentioned they also attended the Type A meeting? The course of sales today starting at around 1:30 AEDT looks strange, and it isn’t the first time I have noticed.

    What might have been happening?

    What do you think?




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.